← Back to all articles
PharmacologyPubMed VerifiedOpen Access

Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant

Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Dos Santos RG

Biomolecules (2022)

Narrative review
Abstract

Review of molecular pathways underlying ayahuasca's therapeutic effects. Covers serotonergic, glutamatergic, dopaminergic, and sigma-1 receptor pathways. Discusses anti-inflammatory mechanisms, neuroplasticity via BDNF and mTOR, and endocannabinoid involvement. Positions ayahuasca as a potential rapid-acting antidepressant.

Citations35
Study TypeNarrative review
molecular pathwaysserotoninglutamatemTORrapid-acting antidepressant
DOI: 10.3390/biom12111618View on PubMed

Related Articles

Pharmacology

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves C, Dos Santos RG et al.

Frontiers in Psychiatry, 2024
Pharmacology

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

Egger K, Aicher HD et al.

Cellular and Molecular Life Sciences, 2024
Pharmacology

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial

Mueller MJ, Aicher HD et al.

International Journal of Neuropsychopharmacology, 2024
Pharmacology

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Aicher HD, Mueller MJ et al.

Frontiers in Psychiatry, 2024